
Febrikast LC 75mg/5mg/10mg Tablet SR
Marketer
Human Biolife India Pvt Ltd
Salt Composition
Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
Overview Febrikast LC 75mg/5mg/10mg Tablet SR
RespiClear 75/5/10mg Extended-Release Tablets combine medications to manage respiratory illnesses marked by thick mucus. This offers relief from productive coughs associated with conditions such as asthma, bronchitis, and the common cold. RespiClear 75/5/10mg Extended-Release Tablets can be taken with or without food, as directed by your physician. Dosage and treatment length depend on your individual response and health status. Continue taking this medication for the prescribed duration; premature discontinuation may lead to symptom recurrence and condition worsening. Inform your doctor of all other medications you are using, as interactions are possible. Common side effects include nausea, indigestion, dry mouth, flu-like symptoms, tiredness, and headache; these are usually temporary. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or activities requiring alertness until the effects are known. Alcohol should be avoided due to increased drowsiness. Disclose any liver or kidney conditions before starting treatment to ensure appropriate dosage. Also, inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Febrikast LC 75mg/5mg/10mg Tablet SR
No text was provided to rewrite.
Uses of Febrikast LC 75mg/5mg/10mg Tablet SR
Management of respiratory conditions involving thick mucus.
Major Benefits of Febrikast LC 75mg/5mg/10mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Febrikast LC 75mg/5mg/10mg Extended-Release Tablets may be consumed with or without food, although consistent daily timing is recommended.
Common Side effects of Febrikast LC 75mg/5mg/10mg Tablet SR:
- Nausea
- Upset stomach
- Dryness in mouth
- Headache
- Fatigue
- Allergic reaction
- Sleepiness
- Flu-like symptoms
How to use Febrikast LC 75mg/5mg/10mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the 75mg/5mg/10mg Febrikast LC Tablet SR whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or not, although consistent timing is preferable.
How Febrikast LC 75mg/5mg/10mg Tablet SR works:
Each Febrikast LC 75mg/5mg/10mg extended-release tablet combines ambroxol, levocetirizine, and montelukast to alleviate respiratory symptoms. Ambroxol, a mucolytic agent, facilitates mucus expulsion by reducing its viscosity. Levocetirizine, an antihistamine, targets allergic rhinitis symptoms such as nasal discharge, ocular irritation, and sneezing. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thereby diminishing airway and nasal inflammation and improving overall symptom control.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining alcohol and Febrikast LC 75mg/5mg/10mg SR tablets. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Febrikast LC 75mg/5mg/10mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards before prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The use of Febrikast LC 75mg/5mg/10mg SR tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Febrikast LC 75mg/5mg/10mg sustained-release tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Febrikast LC 75mg/5mg/10mg SR tablets. Dosage modification of Febrikast LC 75mg/5mg/10mg SR tablets may be necessary; physician consultation is advised. Febrikast LC 75mg/5mg/10mg SR tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Febrikast LC 75mg/5mg/10mg extended-release tablets cautiously. Dosage modification of Febrikast LC 75mg/5mg/10mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Febrikast LC 75mg/5mg/10mg Tablet SR :
Should you forget a dose of your Febrikast LC 75mg/5mg/10mg sustained-release tablet, take it promptly. If, however, your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Febrikast LC 75mg/5mg/10mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
